title: Subacute cutaneous lupus erythematosus induced by capecitabine.
authors.forename: U
authors.initials: U
authors.lastname: Floristan
authors.forename: R A
authors.initials: RA
authors.lastname: Feltes
authors.forename: E
authors.initials: E
authors.lastname: Sendagorta
authors.forename: M
authors.initials: M
authors.lastname: Feito-Rodriguez
authors.forename: P
authors.initials: P
authors.lastname: Ramírez-Marín
authors.forename: C
authors.initials: C
authors.lastname: Vidaurrázaga
authors.forename: M
authors.initials: M
authors.lastname: Casado-Jiménez
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003875:Drug Eruptions / Q000209:etiology*; D005148:Facial Dermatoses / Q000139:chemically induced; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced*
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil